CANADA LIFE ASSURANCE Co

Insurance

Position in OCUL — Ocular Therapeutix, Inc

CIK 1046192 WINNIPEG, A2

Position in OCUL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$182,858

+$81,422 QoQ

Shares Held

18,621

+55.5% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#177

of 257 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. OCUL ranks #58 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	182,365	$90,586,166
2	REGN	Regeneron Pharmaceuticals, Inc.	86,761	$54,098,953
3	ALNY	Alnylam Pharmaceuticals, Inc.	69,102	$20,801,775
4	INCY	Incyte Corp	126,229	$14,309,319
5	ARGX	Argenx SE	14,868	$13,794,084
6	MRNA	Moderna, Inc.	152,228	$10,660,526
7	RPRX	Royalty Pharma plc	185,316	$10,390,668
8	EXEL	Exelixis, Inc.	155,922	$8,483,716

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$182,858	18,621	+55.5%	Shares	Sole	2026-08-13
2026-03-31	$101,436	11,976	0.0%	Shares	Sole	2026-05-14
2025-12-31	$145,388	11,976	-62.5%	Shares	Sole	2026-02-13
2025-09-30	$373,074	31,914	+17.4%	Shares	Sole	2025-11-17
2025-06-30	$252,276	27,185	+127.0%	Shares	Sole	2025-08-15
2025-03-31	$87,784	11,976	-60.4%	Shares	Sole	2025-05-15
2024-12-31	$258,138	30,227	+152.4%	Shares	Sole	2025-02-13
2024-09-30	$104,191	11,976	0.0%	Shares	Sole	2024-11-13
2024-06-30	$81,915	11,976	+197.9%	Shares	Sole	2024-08-12
2022-03-31	$19,899	4,020	0.0%	Shares	Sole	2022-05-12
2021-12-31	$28,019	4,020	0.0%	Shares	Defined	2022-02-14
2021-09-30	$40,200	4,020	0.0%	Shares	Defined	2021-11-15
2021-06-30	$57,003	4,020	0.0%	Shares	Defined	2021-08-11
2021-03-31	$65,968	4,020	0.0%	Shares	Defined	2021-05-17
2020-12-31	$83,214	4,020	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.